Risk factor
Very high price volatility
Profitability factor
Very favourable analyst view
About
Scandinavian ChemoTech AB (publ) provides cancer care and pain management solutions. Its product, IQWave, is an electroporation device, which combines short electric pulses with chemotherapy administrated locally or intravenously used for treating head and neck squamous cell carcinoma, malignant melanoma, basal cell carcinoma, adenocarcinoma of the breast and salivary gland, hypernephroma, kaposi sarcoma, and transitional...
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers.
Target Price
The average target price of CMOTEC-B.ST is 6.3 and suggests 79% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to
Buy
Sell